Nanosonics Limited (ASX:NAN)

Market Cap	1.22B
Revenue (ttm)	183.97M
Net Income (ttm)	16.56M
Shares Out	303.63M
EPS (ttm)	0.05
PE Ratio	75.38
Forward PE	60.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	320,870
Average Volume	754,350
Open	3.920
Previous Close	4.020
Day's Range	3.920 - 4.010
52-Week Range	2.670 - 5.180
Beta	1.75
RSI	52.55
Earnings Date	Aug 22, 2025

About Nanosonics

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technolo...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 466
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NAN

Financial Performance

In 2024, Nanosonics's revenue was 170.01 million, an increase of 2.42% compared to the previous year's 165.99 million. Earnings were 12.97 million, a decrease of -34.76%.